Stay updated on Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial
Sign up to get notified when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.

Latest updates to the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page
- Check3 days agoChange DetectedA new revision entry, v3.6.6, was added to the record history, replacing the previous revision v3.6.5. This update reflects an adjustment to the history metadata rather than substantive content changes.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe Revision tag on the history page was updated from v3.6.4 to v3.6.5, signaling a new version of the record UI.SummaryDifference0.1%

- Check38 days agoChange DetectedThe revision label at the bottom of the study history page was updated from v3.6.3 to v3.6.4, indicating a new version of the record-keeping interface.SummaryDifference0.1%

- Check60 days agoChange DetectedNew release note 'Revision: v3.6.3' was added to the study record history, while the prior 'Revision: v3.6.2' entry was removed. This reflects a site-wide update being logged in the history and does not alter the study data or records.SummaryDifference0.1%

- Check67 days agoChange DetectedThe footer now displays Revision: v3.6.2, replacing Revision: v3.6.0, indicating an update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check82 days agoChange DetectedNew navigation links 'Check who can join' and 'Find Contact Information' were added to the page, improving quick access to enrollment and contact details. The release tag now shows 'Revision: v3.6.0' and the previous 'Revision: v3.5.5' tag has been removed.SummaryDifference0.4%

Stay in the know with updates to Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.